Dr. Abhishek Yadav

• TRAINED AT: Rajiv Gandhi Cancer Institute and Research Centre
• ORGAN SPECIALIZATION:
  Cancer Immunotherapy 
  Cancer Targeted therapy
  Hormone Therapy 
  Novel Tyrosine Kinase Inhibitors 
  Experimental and Research treatment for cancer
  All kind of chemotherapies for solid tumors 
  Management of Haematological malignancies
• PUBLICATIONS:
  1.Yadav A, Goyal P, Agrawal CR, Bothra SJ, Jain P, Choudhury KD, Gupta SK, Sharma M, Bajaj R, Upadhyay A, Dash P, Doval DC. Efficacy and tolerability of nimotuzumab in combination with chemotherapy in recurrent and metastatic squamous cell carcinoma of head and neck at a cancer center in Northern India. Indian J Cancer. 2020 Jan-Mar;57(1):76-83. doi: 10.4103/ijc.IJC_469_18. PMID: 32129298.
  
  
  2.Sharma M, Talwar V, Maheshwari U, Koyyala VPB, Goel V, Goyal S, Dash PK, Batra U, Bajaj R, Yadav A, Goyal P, Doval DC. Role of Maintenance Gemcitabine in Advanced Carcinoma Gallbladder. South Asian J Cancer. 2020 Oct;9(4):204-208. doi: 10.1055/s-0040-1721216. Epub 2021 Jun 12. PMID: 34131572; PMCID: PMC8197654.
  
  
  3.Batra U, Aggarwal M, Jain P, Goyal P, Yadav A, Maheshwari U, Mehta A. Clinical outcome study of crizotinib in immunohistochemistry-proven echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase fusion gene among Indian patients with adenocarcinoma lung. South Asian J Cancer. 2018 Jan-Mar;7(1):61-64. doi: 10.4103/sajc.sajc_215_17. PMID: 29600239; PMCID: PMC5865102.
• REGISTRATION: 71552
• EDUCATION:
  • MBBS, MD (Medicine)
  • DNB Medical Oncology
  • ECMO